HAIFA, Israel, Oct. 23 /PRNewswire/ -- The Board of Directors of UltraSPECT Inc., a provider of enhanced imaging solutions for Nuclear Medicine imaging, has named John W. Schaumburg as its President. Mr. Schaumburg will be responsible for all of UltraSPECT’s operations in North America.
Mr. Schaumburg has more than 25 years of diagnostic imaging and nuclear cardiology management and business development experience. He had previously been the Director of sales for UltraSPECT.
“Mr. Schaumburg’s wealth of experience in the field of both diagnostic and nuclear imaging will enable him to lead and direct UltraSPECT’s business prospectives in North America,” said Dr. Gideon Tolkowsky, Chairman of the Board of UltraSPECT.
About UltraSPECT
UltraSPECT is the market leader in resolution recovery solutions that enhance image quality and productivity in Nuclear Cardiology and Nuclear Medicine. Its products are based on its innovative and patented Wide Beam Reconstruction (WBR) Technology, enabling a gamma camera to provide unsurpassed image quality and improved department productivity.
Optimized for each application, the WBR protocols are fully automatic for all patients regardless of age and size.
For more information about UltraSPECT, visit its website @ www.UltraSPECT.com
UltraSPECT Inc.
CONTACT: John W. Schaumburg of UltraSPECT Inc., +1-516-297-6389
Web site: http://www.UltraSPECT.com/
